Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT05543603Not ApplicableCompleted

Evaluation of the Efficacy of Mouth Rinses With Commercial Mouthwashes to Decrease Viral Load in Saliva in COVID-19 Patients

Role: collaborator

NCT04707742Not ApplicableCompleted

Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients

Role: collaborator

NCT04505709Unknown

Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19

Role: collaborator

All 4 trials loaded